 |
|
Triglycerides, Lipoproteins, and Coronary Artery Disease
MARGARET J. ALBRINK, M.D.
Arch Intern Med. 1962;109(3):345-359.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The present state of knowledge of lipid metabolism and vascular disease has been achieved by advances in many disciplines. The contributions of the basic sciences cannot be clearly separated from those of clinical medicine and epidemiology because of the immense impact of each on the others. The present summary will include, therefore, references to relevant clinical observations as well as to more basic experiments in an attempt to find working hypotheses supported by data from various fields. Particular consideration will be given to the relation of serum triglyceride abnormalities to other serum lipid derangements which have been reported in this disorder.
Serum Lipid Derangements in Coronary Artery Disease
The various findings which have been reported are in part a reflection of available methods and include elevation of serum cholesterol concentration and of cholesterol: phospholipid ratio, a relative or absolute increase in low density or β-lipoproteins, an increased triglyceride concentration, and
. . . [Full Text PDF of this Article]
Author Affiliations
NEW HAVEN, CONN.
Department of Medicine, West Virginia University Medical Center, Morgantown, W. Va.
Footnotes
Submitted for publication Nov. 1, 1961.
Established Investigator of the American Heart Association.
The author's studies quoted in this review were aided, in part, by Grant H-3498-C from the National Heart Institute, National Institutes of Health.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
